FdaApplication
NDA 214985
Identifiers
- fda_app_no: NDA214985
Properties
| Property | Value |
|---|---|
| applicant_name | IDORSIA PHARMACEUTICALS LTD |
| application_type | NDA |
| approval_date | 2022-04-07 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| QUVIVIQ | DARIDOREXANT HYDROCHLORIDE | EQ 25MG BASE | TABLET;ORAL |
| QUVIVIQ | DARIDOREXANT HYDROCHLORIDE | EQ 50MG BASE | TABLET;ORAL |
2 products